New: our quarterly report on the S&P 500, read from 500 companies’ own filings and calls. Read the Q3 2026 report

Sabra Healthcare REIT, Inc.

SBRA

Real Estate Reit Healthcare Facilities

Sabra Healthcare REIT, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $774.6 million, up 10.2% from fiscal 2024.

Revenue
+31.3%
EPS
+22.2%
Free cash flow
n/m
Total debt
−5.99%

Quarter to September 2026, against a year earlier

20.39 0.07 −0.34%

After hours trading: 20.39, unchanged, last trade 4:01pm Eastern.

Market cap
$5.4B
P/E
72.8×
Fwd P/E FY26e
62.6×
Dividend yield
5.89%
F-score
5/9
ROIC
1.95%
Net debt / EBITDA
5.5×
Payout ratio
4.3×

Latest quarter Q3 FY2026 · quarter to September 2026

Revenue growth has picked up four quarters running, from 6.80% to 31.3%.

Q3 FY2026 and the 7 quarters before it
Quarter Revenue, $m Growth, % Op. margin, % EPS, $
Q3 FY26 250 31.3 25.6 0.11
Q2 FY26 236 24.7 (13.6) (0.10)
Q1 FY26 222 20.8 30.6 0.16
Q4 FY25 212 16.2 30.2 0.11
Q3 FY25 190 6.8 30.0 0.09
Q2 FY25 189 7.4 36.0 0.27
Q1 FY25 184 10.1 36.8 0.17
Q4 FY24 182 11.6 36.9 0.19

Against the consensus: revenue beat by 6.18% ($249.6M v $235.1M); adjusted EPS beat by $0.01 ($0.41 v $0.40).

Growth is on the same quarter a year earlier, and EPS is diluted. Negative figures in brackets.

Reports Feb 11, 2027 · Q4 FY26 · consensus EPS $0.40

All quarters →

Capital & Financial Ratios $m

Size
Market Cap 5,360
Revenue ttm 919
Net income ttm 71
Free cash flow ttm (237)
Net debt Q 2,393
Valuation
P/E 72.8 (above 35: high)
Forward P/E FY26e 62.6 (above 35: high)
Price / sales 5.7
Forward P/S FY26e Powerpack
Price / FCF n/m
Price / book 1.8
Financial health
Current ratio Q 1.2
Debt / equity Q 0.9
Interest coverage Q 2.2
Growth
Revenue growth FY26e +11.7% (at or above 10%: strong)
EPS growth FY26e −45.7% (below 0%: weak)
EPS growth FY27e +96.2% (at or above 15%: strong)
EPS growth, 5 yrs e +5.0%
Insiders
Net sold 12m 5
Sells 12m 3
Buys 12m 0
Owned by insiders 0.0%

Green and red mark values outside typical ranges; (Q) is the latest quarter; e marks analysts’ estimates, FY26e the fiscal year ending in 2026; n/m is not meaningful, as a P/E on a loss. How we judge →

Compound annual growth

10y 5y 3y
Sales 12.48% 5.29% 7.43%
Cash Flow 11.15% (0.35%) 3.36%
Earnings 8.45% 2.37% —
Book Value 10.36% (3.70%) (2.60%)

Valuation

P/E against its own 10 years 81.77%
10-year low 10-year high
P/S against its own 10 years 45.33%
10-year low 10-year high
P/B against its own 10 years 96.49%
10-year low 10-year high
EV/Sales against its own 10 years 7.16%
10-year low 10-year high

Dividends

Yield
5.89%
Annual rate
1.20
Payout ratio
428.6%
Growth, 2018–26
−4.94%/yr
  1. 1.80 ’18
  2. 1.80 ’19 +0
  3. 1.35 ’20 −25
  4. 1.20 ’21 −11
  5. 1.20 ’22 +0
  6. 1.20 ’23 +0
  7. 1.20 ’24 +0
  8. 1.20 ’25 +0
  9. 1.20 ’26 +0
paid change on the year, % Powerpack

Analysts’ price targets Wall Street, collected weekly

Analyst price targets

Analysts’ consensus Wall Street average, updated each weekday

2.2
1Buy 2 3Hold 4 5Sell

Ten years at a glance Fiscal years to December

Ten-year view Analyst estimates Powerpack
Group Line 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 TTM Sep ’26 Trend 10 yrs 2026e 2027e 2028e Next 3/yr
Income, $m
Income, $m Revenue 261 408 623 662 599 570 625 648 703 775 919 +12.9% 865 998 1,097 +12.3%
Gross margin, % 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 0.0 pt
EBT 71 159 288 79 156 81 22 19 128 153 65 +8.9%
EBT margin, % 27.35 38.95 46.13 11.97 26.02 14.16 3.47 2.88 18.22 19.81 7.07 (7.5) pt
Net income 70 158 279 69 138 (113) (78) 14 127 156 71 +9.2%
Per share, $
Per share, $ Revenue 3.99 3.87 3.50 3.54 2.90 2.60 2.71 2.80 3.01 3.21 3.60 (2.4%)
Earnings 0.92 1.40 1.51 0.37 0.67 (0.52) (0.34) 0.06 0.54 0.64 0.28 (4.0%)
Cash flow 2.69 1.29 2.02 1.99 1.72 1.63 1.37 1.30 1.33 1.44 1.57 (6.7%)
Capex (0.87) (2.62) 0.52 1.35 (0.60) (0.19) (0.26) 0.36 (0.41) (1.68) (2.49) +7.6%
Free cash flow 1.83 (1.33) 2.55 3.34 1.12 1.44 1.11 1.66 0.92 (0.24) (0.93) n/m
Book value 15.56 32.54 18.25 18.64 16.53 15.43 13.23 12.12 11.74 11.70 11.12 (3.1%)
Shares, m 65 106 178 187 206 219 231 231 233 241 250 +15.6%
Valuation, ×
Valuation, × P/E 26.76 13.70 10.84 62.76 25.93 n/m n/m 283.80 32.07 29.14 72.82 60.6
P/S 6.17 4.94 4.71 6.04 5.98 5.21 4.66 5.07 5.75 5.90 5.67 5.4
P/B 1.58 0.59 0.90 1.15 1.05 0.88 0.95 1.17 1.48 1.62 1.83 1.1
EV/Sales 10.68 11.81 9.80 9.59 9.84 9.21 8.59 8.72 9.09 9.06 8.27 9.6
EV/FCF 23.32 (34.25) 13.46 10.16 25.46 16.65 20.93 14.68 29.69 (122.74) (32.10) (0.3)
Cash, $m
Cash, $m Operating cash flow 176 136 361 372 355 356 316 301 311 349 401 +7.9%
Capex (57) (277) 93 252 (124) (41) (59) 84 (95) (406) (637) +24.5%
Free cash flow 119 (141) 454 625 231 315 256 385 215 (57) (237) n/m
Balance, $m
Balance, $m Working capital 91 599 79 48 22 372 323 330 391 393 28 +17.6%
Net debt 1,176 2,807 3,172 2,353 2,307 2,279 2,453 2,367 2,351 2,451 2,393 +8.5%
Shareholders’ equity 1,016 3,437 3,255 3,488 3,409 3,380 3,056 2,803 2,741 2,824 2,841 +12.0%
Returns, %
Returns, % ROA 2.54 3.19 3.93 1.08 2.30 (1.90) (1.32) 0.25 2.37 2.88 1.30 +0.3 pt
ROIC 3.77 1.96 2.97 2.33 2.75 2.22 1.60 2.50 2.93 3.04 1.95 (0.7) pt
ROE 5.80 6.65 8.05 2.05 4.01 (3.34) (2.41) 0.47 4.57 5.59 2.52 (0.2) pt
People
People Employees 14 61 31 34 38 42 42 48 50 58 — +17.1%
Revenue/emp, $m 18.61 6.69 20.11 19.46 15.75 13.56 14.88 13.49 14.06 13.36 — (3.6%)
Negative figures in brackets.
estimates

All 10 years →

Fiscal years to Dec 2025 · latest quarter Sep 2026 · fundamentals updated Nov 18, 2026

Sabra Healthcare REIT, Inc. vs peers in Reit Healthcare Facilities (Q) = latest quarter vs a year earlier

Company Market cap P/E Fwd P/E Revenue growth (Q) EPS growth (Q) FCF growth (Q) Gross margin (Q) EBIT margin (Q) Compare
OHI Omega Healthcare Investors, Inc. $14.0B 18.2× 19.4× FY26e +9.30% (above 0%: growing) −54.24% (below 0%: shrinking) −1,060.46% (below 0%: shrinking) 100.00% 35.62% Compare
DOC Healthpeak Properties, Inc. $13.6B 35.6× 48.3× FY26e +16.29% (above 0%: growing) n/m −1,493.36% (below 0%: shrinking) 53.78% 13.33% Compare
AHR American Healthcare REIT, Inc. $13.5B 117× 89.0× FY26e +29.53% (above 0%: growing) −57.58% (below 0%: shrinking) +19.47% (above 0%: growing) 22.21% 6.36% Compare
CTRE CareTrust REIT, Inc. $9.5B 23.1× 24.9× FY26e +33.16% (above 0%: growing) 0.00% −2,473.98% (below 0%: shrinking) 98.38% 62.35% Compare
HR Healthcare Realty Trust Incorporated $6.6B — (loss-making) — (loss-making) −3.74% (below 0%: shrinking) n/m −65.19% (below 0%: shrinking) 64.26% 14.64% Compare
SBRA Sabra Healthcare REIT, Inc. $5.4B 72.8× 62.6× FY26e +31.32% (above 0%: growing) +22.22% (above 0%: growing) +26.70% (above 0%: growing) 100.00% 25.59%
NHI National Health Investors, Inc. $3.0B 4.3× 4.5× FY26e +26.31% (above 0%: growing) +1,564.39% (above 0%: growing) +782.13% (above 0%: growing) 68.11% 26.23% Compare
LTC LTC Properties, Inc. $2.4B 4.4× 5.4× FY26e +66.32% (above 0%: growing) n/m −126.46% (below 0%: shrinking) 100.00% 303.46% Compare
DHC Diversified Healthcare Trust $1.7B — (loss-making) — (loss-making) −5.41% (below 0%: shrinking) n/m +100.70% (above 0%: growing) 21.97% (3.97%) Compare
Median of peers $8.0B 20.7× 22.2× +21.30% −27.12% −95.82% 66.19% 20.43%

All 17 Reit Healthcare Facilities stocks →

Pay and ownership Proxy statement filed Apr 24, 2026

Chief executive’s pay

Year Total pay Actually paid $100 invested
2025 8.55m 12.70m —
2024 8.48m 14.34m —
2023 8.22m 12.21m —
2022 6.65m 7.29m —
2021 6.09m 1.13m —

Ownership

Directors and executive officers, together 1.09%
BlackRock, Inc. 13.67%
The Vanguard Group, Inc. 13.54%
Principal Real Estate Investors LLC 8.46%
Total pay is as the Summary Compensation Table states it; actually paid revalues the year’s share awards at its end, as the SEC’s pay-versus-performance rule asks. $100 invested is what $100 in the company’s shares at the start of the earliest year shown was worth at each year’s end. Ownership is the proxy’s own table: the directors and officers as a group, and every holder of 5% or more. Read the proxy statement

Sabra Healthcare REIT, Inc. (SBRA) Latest News

20 more headlines
All SBRA news, as stories →

SBRA metrics, ten years each

stockrow.com/SBRA · Data as of Nov 18, 2026 · For information only; not investment advice. · © 2026 stockrow.com